205 related articles for article (PubMed ID: 37589744)
1. AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/STAT3 axis.
Wu Y; Xu M; Feng Z; Wu H; Wu J; Ha X; Wu Y; Chen S; Xu F; Wen H; Li S; Wu X
Cell Mol Life Sci; 2023 Aug; 80(9):256. PubMed ID: 37589744
[TBL] [Abstract][Full Text] [Related]
2. Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer.
Dai C; Dai SY; Gao Y; Yan T; Zhou QY; Liu SJ; Liu X; Deng DN; Wang DH; Qin QF; Zi D
Epigenetics; 2023 Dec; 18(1):2175565. PubMed ID: 36908025
[TBL] [Abstract][Full Text] [Related]
3. Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer.
Lv J; Zhang Y; Yang M; Qiao L; Wang H; Jiang H; Fu M; Qin J; Xu S
Cancer Gene Ther; 2024 Jan; 31(1):108-118. PubMed ID: 38102461
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression.
Han Y; Zheng Y; You J; Han Y; Lu X; Wang X; Shi C; Zhu W
Clin Transl Oncol; 2023 Oct; 25(10):2901-2910. PubMed ID: 37000289
[TBL] [Abstract][Full Text] [Related]
5. CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination.
Zhu Y; Liang L; Zhao Y; Li J; Zeng J; Yuan Y; Li N; Wu L
J Nanobiotechnology; 2024 Jan; 22(1):35. PubMed ID: 38243224
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_0001741 Suppresses Ovarian Cancer Cell Proliferations Through Adsorption of miR-188-5p and Promotion of FOXN2 Expression.
Wang H; Liang C; Lin J; Dong Y; Wang Y; Xia L
Mol Biotechnol; 2024 Jun; 66(6):1477-1483. PubMed ID: 37318741
[TBL] [Abstract][Full Text] [Related]
7. hsa_circ_0003176 Suppresses the Progression of Non-Small-Cell Lung Cancer via Regulating miR-182-5p/RBM5 Axis.
Yang F; Pei Y; Xu W; Rong L
Dis Markers; 2022; 2022():8402116. PubMed ID: 36193508
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.
Ji J; Li C; Wang J; Wang L; Huang H; Li Y; Fang J
Cell Cycle; 2022 Apr; 21(7):685-696. PubMed ID: 35113003
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637/KLK4 axis.
Zhang M; Xia B; Xu Y; Zhang Y; Xu J; Lou G
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1224-1233. PubMed ID: 30945557
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.
Liu T; Yuan L; Zou X
J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327
[TBL] [Abstract][Full Text] [Related]
12. hsa_circ_0006916 promotes hepatocellular carcinoma progression by activating the miR-337-3p/STAT3 axis.
Zhou XY; Yang H; Bai YQ; Li XL; Han SY; Zhou BX
Cell Mol Biol Lett; 2020 Nov; 25(1):47. PubMed ID: 33292166
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of hsa_circ_0007874 suppresses the progression of ovarian cancer by regulating the miR-760/SOCS3 pathway.
Li L; Yu P; Zhang P; Wu H; Chen Q; Li S; Wang Y
Cancer Med; 2020 Apr; 9(7):2491-2499. PubMed ID: 32023009
[TBL] [Abstract][Full Text] [Related]
14. Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network.
Huang H; Yan L; Zhong J; Hong L; Zhang N; Luo X
Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):275-286. PubMed ID: 35196944
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G
J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis.
You J; Han Y; Qiao H; Han Y; Lu X; Lu Y; Wang X; Kai H; Zheng Y
Aging (Albany NY); 2022 Jun; 14(11):4699-4713. PubMed ID: 35687899
[TBL] [Abstract][Full Text] [Related]
17. Circ_0026123 promotes cisplatin resistance and progression of ovarian cancer by upregulating RAB1A through sequestering miR-543.
Wei L; He W; Zhao H; Zhao P
Anticancer Drugs; 2022 Nov; 33(10):1069-1080. PubMed ID: 36255068
[TBL] [Abstract][Full Text] [Related]
18. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
Sheng H; Wang X
Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
[TBL] [Abstract][Full Text] [Related]
20. Expression of circ-PHC3 enhances ovarian cancer progression via regulation of the miR-497-5p/SOX9 pathway.
Wang H; Lan S; Wang L; Zhao J; Jia X; Xu J; Sun G; Liu L; Gong S; Wang N; Shan B; Zhang F; Zhang Z
J Ovarian Res; 2023 Jul; 16(1):142. PubMed ID: 37468993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
